These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25086956)

  • 1. Close correlation between CXCR4 and VEGF expression and frequent CXCR7 expression in rhabdomyosarcoma.
    Miyoshi K; Kohashi K; Fushimi F; Yamamoto H; Kishimoto J; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2014 Sep; 45(9):1900-9. PubMed ID: 25086956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas.
    Grymula K; Tarnowski M; Wysoczynski M; Drukala J; Barr FG; Ratajczak J; Kucia M; Ratajczak MZ
    Int J Cancer; 2010 Dec; 127(11):2554-68. PubMed ID: 20162608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
    Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
    Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the Chemokine Receptors CXCR3, CXCR4, CXCR7 and Their Ligands in Rhabdomyosarcoma.
    San-Miguel T; Pinto S; Navarro L; Callaghan RC; Monteagudo C; López-Ginés C; Cerdá-Nicolás M; Gil-Benso R
    Pathol Oncol Res; 2015 Sep; 21(4):1191-9. PubMed ID: 26037167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.
    Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D
    Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of expression of stromal-derived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas.
    Tarnowski M; Grymula K; Reca R; Jankowski K; Maksym R; Tarnowska J; Przybylski G; Barr FG; Kucia M; Ratajczak MZ
    Mol Cancer Res; 2010 Jan; 8(1):1-14. PubMed ID: 20068066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma.
    Chifu I; Heinze B; Fuss CT; Lang K; Kroiss M; Kircher S; Ronchi CL; Altieri B; Schirbel A; Fassnacht M; Hahner S
    Front Endocrinol (Lausanne); 2020; 11():597878. PubMed ID: 33281749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.
    Kuda M; Kohashi K; Yamada Y; Maekawa A; Kinoshita Y; Nakatsura T; Iwamoto Y; Taguchi T; Oda Y
    Tumour Biol; 2016 Apr; 37(4):5213-23. PubMed ID: 26553361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
    Wu W; Qian L; Chen X; Ding B
    Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
    Long P; Sun F; Ma Y; Huang Y
    Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of IGF2, IGFBP2 and p63 proteins in rhabdomyosarcoma tumors.
    Yu Y; Fu L; Wang S; Jin Y; Han S; Chu P; Lu J; Guo Y; He L; Ni X
    Growth Horm IGF Res; 2017 Apr; 33():17-22. PubMed ID: 28129571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-X-C chemokine receptor 7: a functionally associated molecular marker for bladder cancer.
    Yates TJ; Knapp J; Gosalbez M; Lokeshwar SD; Gomez CS; Benitez A; Ekwenna OO; Young EE; Manoharan M; Lokeshwar VB
    Cancer; 2013 Jan; 119(1):61-71. PubMed ID: 22736438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
    van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
    Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR7 expression correlates with tumor depth in cutaneous squamous cell carcinoma skin lesions and promotes tumor cell survival through ERK activation.
    Hu SC; Yu HS; Yen FL; Chen GS; Lan CC
    Exp Dermatol; 2014 Dec; 23(12):902-8. PubMed ID: 25256412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma.
    Zibat A; Missiaglia E; Rosenberger A; Pritchard-Jones K; Shipley J; Hahn H; Fulda S
    Oncogene; 2010 Dec; 29(48):6323-30. PubMed ID: 20818440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different expression profiles of Y-box-binding protein-1 and multidrug resistance-associated proteins between alveolar and embryonal rhabdomyosarcoma.
    Oda Y; Kohashi K; Yamamoto H; Tamiya S; Kohno K; Kuwano M; Iwamoto Y; Tajiri T; Taguchi T; Tsuneyoshi M
    Cancer Sci; 2008 Apr; 99(4):726-32. PubMed ID: 18377424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer.
    D'Alterio C; Consales C; Polimeno M; Franco R; Cindolo L; Portella L; Cioffi M; Calemma R; Marra L; Claudio L; Perdonà S; Pignata S; Facchini G; Cartenì G; Longo N; Pucci L; Ottaiano A; Costantini S; Castello G; Scala S
    Curr Cancer Drug Targets; 2010 Nov; 10(7):772-81. PubMed ID: 20578990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients.
    Sand LG; Scotlandi K; Berghuis D; Snaar-Jagalska BE; Picci P; Schmidt T; Szuhai K; Hogendoorn PC
    Eur J Cancer; 2015 Nov; 51(17):2624-33. PubMed ID: 26428435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine receptor CXCR4 expression is correlated with VEGF expression and poor survival in soft-tissue sarcoma.
    Oda Y; Tateishi N; Matono H; Matsuura S; Yamamaoto H; Tamiya S; Yokoyama R; Matsuda S; Iwamoto Y; Tsuneyoshi M
    Int J Cancer; 2009 Apr; 124(8):1852-9. PubMed ID: 19107931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.